In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

NicOx licenses Pfizer technology for eye uses; concludes

Executive Summary

French biotech NicOx SA (compounds that deliver nitric oxide (NO) to treat inflammatory and cardiovascular diseases) licensed Pfizer exclusive rights to use its NO-donating technology across all ophthalmic areas.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Concluded
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes Equity

Related Companies

Advertisement
UsernamePublicRestriction

Register